|
|
||||||||
In cerebral malaria, the use of currently recommended doses of intravenous quinine may result in subtherapeutic plasma concentrations during the critical first 24 hours of treatment. A loading dose of quinine (20 mg/kg quinine dihydrochloride, equivalent to 16.7 mg/kg base, infused over 4 hours) proved a rapid and safe method of achieving plasma concentrations above the high minimum inhibitory concentrations for Plasmodium falciparum prevalent in Eastern Thailand.
Accepted for publication June 16, 1982.
Address reprint requests to: Dr. David A. Warrell, Faculty of Tropical Medicine, Mahidol University, 420/6 Rajvithi Road, Bangkok 4, Thailand.
* This study was part of the Wellcome-Mahidol University, Oxford Tropical Medicine Research Programme funded by the Wellcome Trust of Great Britain.
This article has been cited by other articles:
![]() |
N. Day and A. M. Dondorp The Management of Patients with Severe Malaria Am J Trop Med Hyg, December 1, 2007; 77(6_Suppl): 29 - 35. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Pasvol The treatment of complicated and severe malaria Br. Med. Bull., February 22, 2006; 75-76(1): 29 - 47. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Wambebe, E. Sokomba, and G. J. Amabeoku Some behavioural effects of quinine in mice J Psychopharmacol, January 1, 1989; 3(3): 156 - 168. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |